Impact of the ACE2/Ang(1-7)/Mas axis and the angiotensin A/alamandine/ MrgD axis on weight regulation
Project Description:
The classic ACE/AngII/AT1 receptor axis of the Renin Angiotensin System (RAS) regulates cardiovascular and metabolic functions. Blockade of AT1 receptors prevents development of obesity by normalizing energy homeostasis via leptin, brain, and gut related mechanisms. An alternative RAS pathway (ACE2/Ang(1-7)/Mas) is established to also be involved although it remains unknown whether due to an adipocyte or brain related mechanism. We aim to investigate tissue specificity by using transgenic mouse models with an adipocyte and brain selective overexpression or deficiency of Mas or Ang(1-7). We further want to clarify whether the Ang(1-7)-dependent weight loss after ARB treatment is not only related to Mas but also to MrgD receptors.
Experimental Methods:
- Working with genetically modified mice including breeding strategies
- Chronic treatment of animals with drugs
- Phenotyping of mice including measurement of blood pressure, heart rate, glucose control, energy expenditure, body weight and fat mass
- Multiplex, ELISA, RIA analyses of adipokines and endocrine parameters
- DNA and RNA extraction
- PCR, qPCR (e.g. for analyzing components of the RAS in different tissue)
Luis Daniel Hernandez Torres
Institute of Experimental and Clinical Pharmacology and Toxicology
Gebäude CBBM
,
Raum 3.OG
luis.hernandeztorres(at)uni-luebeck.de
Walter Raasch
Institute of Experimental and Clinical Pharmacology and Toxiology
Gebäude CBBM, 3.OG
,
Raum 66
walter.raasch(at)pharma.uni-luebeck.de
+49 451 3101 7229
Michael Bader
Max Delbrück Center for Molecular Medicine
mbader(at)mdc-berlin.de
+49 30 9406 2193